PharmaLive – Orphan designation qualifies drug companies for development incentives that include financial grants, increased access to regulatory agencies, protocol assistance, extended periods of market exclusivity, and fee reductions and waivers.
Science Magazine – A new report on how the next U.S. president should manage the nation’s science portfolio comes with an invisible sticker on its cover: Open and read immediately if Donald Trump is elected.
BuzzFeed News – In December, US lawmakers banned the FDA from evaluating clinical trials for any genetic modifications that affected the next generation. As that law expires, some are worried that the ban will be quietly renewed without discussion or debate.
NPR 13.7 – This election season, voters should be evaluating the presidential candidates' attitudes toward science. ScienceDebate.org proposes a set of 20 science and science policy questions for all candidates.
TECH Insider – Strict rules govern which DNA samples are added to the FBI’s national database, but they don’t apply to the police departments’ private databases, which are subject to no state or federal regulation or oversight.
Futurism – Bill Gates has pledged an additional $35 million to fund gene drive research. The research aims to eradicate malaria with the genetic engineering of the mosquitoes responsible for its spread.